{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:01:23Z","timestamp":1794693683070,"version":"4.9.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Nutr"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41430-025-01653-7","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:58:46Z","timestamp":1756997926000},"page":"1160-1163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Semaglutide-induced Wernicke encephalopathy: a comprehensive analysis"],"prefix":"10.1038","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4430-4951","authenticated-orcid":false,"given":"C\u00e9cile","family":"Gras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"De Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nacima","family":"Oussedik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Daclin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venceslas","family":"Bourdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Callot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghiles","family":"Chegrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Rives-Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9626-3571","authenticated-orcid":false,"given":"Laurent","family":"Chouchana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"1653_CR1","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989\u20131002.","journal-title":"N Engl J Med"},{"key":"1653_CR2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.61783","author":"K Sheth","year":"2024","unstructured":"Sheth K, Garza E, Saju A, Nazir N, Agarwal A. Wernicke encephalopathy associated with semaglutide use. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.61783.","journal-title":"Cureus"},{"key":"1653_CR3","unstructured":"Foster S, Kyle A. From weight loss to neurological deficits: a case of wernicke\u2019s encephalopathy stemming from prescription weight loss medication. 2023. https:\/\/www.emra.org\/emresident\/article\/wernicke-july-2023 (accessed 15 Jan2025)."},{"key":"1653_CR4","doi-asserted-by":"publisher","first-page":"S2964","DOI":"10.14309\/01.ajg.0001048112.46649.58","volume":"119","author":"SA Ali","year":"2024","unstructured":"Ali SA, Khadra M, Sitto M, Graifman M, Gietzen J. S4686 semaglutide\u2019s hidden perils: a rare case of malnutrition and wernicke encephalopathy. Am J Gastroenterol. 2024;119:S2964\u2013S2964.","journal-title":"Am J Gastroenterol"},{"key":"1653_CR5","doi-asserted-by":"publisher","first-page":"S2967","DOI":"10.14309\/01.ajg.0001048128.46369.17","volume":"119","author":"N Sharma","year":"2024","unstructured":"Sharma N, Vura NVRK, Shweikeh F, Ramirez-Osoria LC, Chakinala RC, Sharma AN. S4690 semaglutide-linked dry beriberi: a rare adverse reaction. Am J Gastroenterol. 2024;119:S2967\u2013S2968.","journal-title":"Am J Gastroenterol"},{"key":"1653_CR6","first-page":"e104","volume":"57","author":"C Verstraeten","year":"2022","unstructured":"Verstraeten C, Barbier A, Jonneaux C, Faure G, Guillain P, Dervaux D, et al. Cas clinique: enc\u00e9phalopathie de Gayet-Wernicke sous inhibiteur de la pompe \u00e0 proton au long cours. Pharm Clin. 2022;57:e104.","journal-title":"Pharm Clin"},{"key":"1653_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/nutrit\/nuv107","volume":"74","author":"G Sechi","year":"2016","unstructured":"Sechi G, Sechi E, Fois C, Kumar N. Advances in clinical determinants and neurological manifestations of B vitamin deficiency in adults. Nutr Rev. 2016;74:281\u2013300.","journal-title":"Nutr Rev"},{"key":"1653_CR8","doi-asserted-by":"publisher","first-page":"e001704","DOI":"10.1136\/bmjgast-2024-001704","volume":"12","author":"C Aneke-Nash","year":"2025","unstructured":"Aneke-Nash C, Hung KS, Wall-Wieler E, Zheng F, Sharaiha RZ. Comparing the risk of gastroparesis following different modalities for treating obesity: semaglutide versus bupropion-naltrexone versus sleeve gastrectomy\u2014a retrospective cohort study. BMJ Open Gastroenterol. 2025;12:e001704.","journal-title":"BMJ Open Gastroenterol"},{"key":"1653_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205\u201316.","journal-title":"N Engl J Med"},{"key":"1653_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A Randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373:11\u201322.","journal-title":"N Engl J Med"}],"container-title":["European Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41430-025-01653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41430-025-01653-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41430-025-01653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:01:57Z","timestamp":1762124517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41430-025-01653-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1653"],"URL":"https:\/\/doi.org\/10.1038\/s41430-025-01653-7","relation":{},"ISSN":["0954-3007","1476-5640"],"issn-type":[{"value":"0954-3007","type":"print"},{"value":"1476-5640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No funding was received for this study. None of the authors have any financial or personal relationships with other people or organizations that could influence the design, conduct, or reporting of this work. CRL received remuneration for attending symposia by Nestl\u00e9 Health Science\u00ae.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in compliance with the principles of Good Clinical Practices and the Declaration of Helsinki. Due to its retrospective nature, in accordance with French law, the study was determined not to require ethics committee review. Individual informed consent has been obtained regarding this case report, which has been reported to the French Pharmacovigilance system under the number FR-AFSSAPS-PV2024001276. VigiBase is managed by the Uppsala Monitoring Center (Uppsala, Sweden), an independent center for drug safety and scientific research for WHO. Information from VigiBase comes from a variety of sources and the probability that the suspected adverse effect is drug-related is not the same in all cases. The findings of this study do not represent the opinion of the Uppsala Monitoring Center (Uppsala, Sweden) or the World Health Organization and only reflect the authors\u2019 opinion. All safety reports from these databases are anonymized with no possibility to trace back patients\u2019 or reporters\u2019 personal information. Data were treated following EU and national legislation regarding the protection of personal data (e.g. the Data Protection Directive 95\/46\/EC and Regulation (EC) No 45\/2001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}